Latest news
Loading news…
VERAXA Biotech
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Heidelberg, Baden-Wurttemberg, Germany Founded 2017 11-50 employees For Profit
VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.
VERAXA Biotech on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$80.91M
Funding Rounds
3
Last Funding
Acquisitions
1
Monthly Visits
Contacts
4
Ticker
VRXA
NASDAQ
Patents
6
5 trademarks
About VERAXA Biotech
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- VRXA
- Exchange
- NASDAQ
- IPO date
- Jun 10, 2026
- Raised at IPO
- $220M
- Valuation at IPO
- $275M
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Patents granted
- 6
- Trademarks
- 5
- Top patent class
- Organic Chemistry
- IT spend
- $521.81K
Company Info
- Founded
- 2017
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 59
- HQ
- Heidelberg, Baden-Wurttemberg, Germany
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jun 10, 2026
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 3.1
- Trend (30d)
- 7.9
- Trend (90d)
- 9.9
- Last leadership hire
- Jul 13, 2026
VERAXA Biotech Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
VERAXA Biotech Acquisitions
1 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Synimmune GmbH | — | 2023-12-29 | VERAXA Biotech | BiotechnologyClinical TrialsEducation | Germany |
1–1 of 1Show
Page 1 / 1
VERAXA Biotech Key People
Co-Founder & Chief Scientific Officer
4
professional contacts at VERAXA Biotech
Contact execs at VERAXA Biotech →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to VERAXA Biotech
Loading news…
FAQs about VERAXA Biotech
People who checked this page also checked these
Sectors VERAXA Biotech invests & acquires in
Browse the full Acquirezy directory.